Latanoprost / Timolol Crescent Pharma

Timolol maleate and Latanoprost, the active ingredients in Latanoprost / Timolol Crescent Pharma, are a beta‑blocker and a prostaglandin analog presented as an ophthalmic solution for ocular (topical) use. They treat open‑angle glaucoma and ocular hypertension by lowering intra‑ocular pressure.

GNH USA supplies Latanoprost / Timolol Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is used in the management of ocular conditions that require reduction of intra‑ocular pressure.

Open‑angle glaucoma: lowers intra‑ocular pressure to slow disease progression. Ocular hypertension: reduces eye pressure to prevent conversion to glaucoma. Secondary glaucoma: provides adjunctive pressure control when monotherapy is insufficient.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Conjunctival hyperemia (redness). - Increased eyelash length or density. - Darkening of the iris color. - Mild headache.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, swelling). - Sudden loss of vision or acute ocular pain. - Systemic bradycardia or hypotension. - Bronchospasm in susceptible individuals. - Persistent corneal ulceration. - Significant worsening of asthma or COPD.

Before using Latanoprost/Timolol, consider the following precautions: - Assess cardiovascular status: avoid in patients with severe bradycardia, heart block, or uncontrolled heart failure. - Screen for respiratory disease: use with caution in asthma or COPD due to beta‑blocker effects. - Monitor for ocular allergy: discontinue if severe conjunctival reaction occurs. - Avoid concurrent use with other beta‑blocker eye drops to prevent additive systemic absorption. - Pregnancy and lactation: prescribe only if clearly needed after risk‑benefit assessment. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines as follows:

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: may cause additive bradycardia or hypotension. - Sympathomimetic ophthalmic agents (e.g., phenylephrine): may reduce the ocular hypotensive effect. - Other prostaglandin analog eye drops: increased risk of ocular irritation and hyperemia.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives: monitor blood pressure for additive lowering. - Inhaled beta‑agonists (e.g., albuterol): watch for reduced bronchodilator response. - Topical anesthetics: may increase corneal toxicity when used together.